Transverse Cerebellar Diameter and Abdominal Circumference Ratio Versus Mid-Thigh Circumference and Femur Length Ratio in Assessment of Gestational Age in Normal and Growth Restricted Fetuses
1 other identifier
observational
100
1 country
1
Brief Summary
The aim of this research was to examine the accuracy of transcerebellar diameter to abdominal circumference ratio (TCD/AC) and mid-thigh circumference and femur length (MTC/FL) in estimating the gestational age of healthy and abnormally growing fetuses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedFirst Submitted
Initial submission to the registry
June 23, 2026
CompletedFirst Posted
Study publicly available on registry
June 30, 2026
CompletedJune 30, 2026
June 1, 2026
1 year
June 23, 2026
June 23, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Diagnostic accuracy of transcerebellar diameter to abdominal circumference ratio (TCD/AC) ratio
Assessment of the diagnostic performance of the transcerebellar diameter to abdominal circumference ratio (TCD/AC) in predicting intrauterine growth restriction (IUGR)
At the time of ultrasound examination (24-28 weeks of gestation)
Study Arms (2)
Group A
Pregnant women with normal fetal growth.
Group B
Pregnant women suffering from intrauterine growth restriction (IUGR).
Interventions
All enrolled pregnant women underwent a standardized obstetric ultrasound examination between 24 and 28 weeks of gestation.
Eligibility Criteria
This prospective study was conducted on 100 pregnant cases at the department of Obstetrics of Tanta University Hospital.
You may qualify if:
- Pregnant women aged 18 to 35 years old.
- weeks of gestation
- Primigravida
- Single viable fetus
- Reliable Last Menstrual Period (LMP) or first trimester ultrasonography to confirm gestational age.
You may not qualify if:
- Chromosomal abnormalities.
- Any medical disease that affect fetal growth.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
Tanta University
Tanta, El-Gharbia, 31527, Egypt
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident at Obstetrics and Gynecology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Study Record Dates
First Submitted
June 23, 2026
First Posted
June 30, 2026
Study Start
October 1, 2023
Primary Completion
October 1, 2024
Study Completion
October 1, 2024
Last Updated
June 30, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- After the end of study for one year.
- Access Criteria
- The data will be available upon a reasonable request from the corresponding author.
The data will be available upon a reasonable request from the corresponding author after the end of study for one year.